Clinical Trial Update: Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing saxagliptin plus metformin versus saxagliptin or metformin alone in women with polycystic ovary syndrome and impaired glucose regulation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Glucose Regulation
• Polycystic Ovary Syndrome

Drugs mentioned

• Glucophage (metformin)
• Onglyza (saxagliptin) (saxagliptin)

Snippet

Sponsor: Woman's | Conditions: Polycystic Ovary Syndrome, Disorder of Glucose Regulation | Phase 3 | Status: COMPLETED | Results posted: 2017-06-28